News | July 06, 2024
Nephro Care India lists at 90% premium
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Dyslipidemia is a critical risk factor for cardiovascular diseases
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
This plant is located at Baddi, Himachal Pradesh spread over an area of 2.85 acres
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
Renews GMP certifications for India and Malaysia sites
The company will now explore a buyer for its manufacturing site and exit in due course
Subscribe To Our Newsletter & Stay Updated
